To date, gene expression in tumors has been typically profiled by capturing messenger RNAs; however, they represent only a fraction of the molecules detected
All of these monoclonal antibodies have been expressly designed for use as an integral component within solid phase enzyme immunoassay test procedures, especially ELISAs